undefined

 

 

Bacillus coagulans, earlier known as lactobacillus sporogenes and generally termed as Lactic Acid Bacteria (LAB), is a gram positive, spore-forming bacterium utilized as a probiotic. Bacillus coagulans is non-pathogenic, beneficial and safe for human consumption. It is used in various therapeutic treatments such as digestive problems, diarrhea, constipation, lactose intolerance, bacterial vaginosis, cholesterol reduction and immunity enhancement. Bacillus coagulans is compatible with vitamins, enzymes, electrolytes, proteins and carbohydrates, which makes it a cost-effective probiotic that can be incorporated into a wide range of foods. Bacillus coagulans is GRAS affirmed and being a tough and stable probiotic that can withstand a harsh acidic environment, it is a popular probiotic choice in food and pharmaceutical industries.

Request a Sample of this Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-8434

Bacillus Coagulans – A Safe, Natural and Effective Way to Balance Intestinal System and Maintain Strong Immune and Digestive System

The bacillus coagulans market is driven by applications in functional foods and beverages such as breakfast cereals, sports beverages, protein bars and shakes and bakery products. Bacillus coagulans is a suitable choice for bakery products as it can withstand high temperatures required during baking. Besides usage in the food and beverages industry, bacillus coagulans also finds application in the supplements sector as a probiotic. With rising health concerns among the global population, probiotics have been witnessing high demand, which in turn has been driving the demand for bacillus coagulans. The use of probiotics containing bacillus coagulans is a safe, natural and effective way to balance the intestinal system and maintain a strong immune and digestive system.

The lack of awareness among consumers regarding the effectiveness of bacillus coagulans restricts the growth of the market to an extent. The increasing demand for bacillus coagulans products in emerging economies is expected to provide growth opportunities for market participants.

Global Bacillus Coagulans Market: Market Participants

Sabinsa Corp., Mitsubishi, Syngen Biotech Co., Unique Biotech, Aumgene Bioscience, Microbax, JBH Biotech, sanzyme are some of the key players identified in the global Bacillus coagulans market.

Global Bacillus Coagulans Market: Key Developments

Increasing investments on R&D activities to launch innovative products in functional foods are propelling the bacillus coagulans market growth. Across the globe, strains expressing unique and particular characteristics are of great interest. Although a reasonable number of commercial probiotic strains are available, novel strains with better potency are being continuously searched, which may enable health benefits with the specific targeted functional properties. Manufacturers are focusing on developing innovative and effective solutions through fermentation technology to improve the overall yield and quality of the product.

On 14th September, 2017, Sabinsa Corp. was successfully granted a U.S. patent for its shelf stable probiotic LactoSpore® Bacillus coagulans product combined with cranberry seed fibers. With the aid of natural fiber from cranberry, the viable colony count of the bacillus coagulans was found to increase. Studies have shown that lactospore® is found to reverse depression symptoms in patients suffering from IBS as well as improve cholesterol levels.

Global Bacillus Coagulans Market: Opportunities for Market Participants

Asia Pacific holds a substantial revenue share in the global bacillus coagulans market with ASEAN, India, and China pegged to be prominent markets for bacillus coagulans. North America is pegged to be next in line after Asia Pacific. Asia Pacific is also projected to be a fast growing market, owing to the rising healthcare spending in the region.

Ask An Analyst @ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-8434

Regional analysis includes:

  • North America (U.S., Canada)
  • Latin America (Mexico. Brazil)
  • Western Europe (Germany, Italy, France, U.K, Spain)
  • Eastern Europe (Poland, Russia)
  • Asia Pacific (China, India, ASEAN, Australia & New Zealand)
  • Japan
  • Middle East and Africa (GCC Countries, S. Africa, Northern Africa)

Bacillus Coagulans Market: Segmentation

Segmentation of the bacillus coagulans market on the basis of the type:

  • Bacillus coagulans type 1
  • Bacillus coagulans type 2
  • Bacillus coagulans type 3

Segmentation of the bacillus coagulans market on the basis of the end use:

  • Food and beverage
  • Bakery products
  • Dairy products
  • Processed foods
  • Pharmaceuticals
  • Dietary supplements
  • Animal feed
  • Other

Segmentation of the bacillus coagulans market on the basis of the distribution channel:

  • Wholesale
  • Online retailer
  • Supermarket
  • Specialty stores

Buy Complete Report @ https://www.futuremarketinsights.com/checkout/8434

Report Highlights:

Related Reports :

Microencapsulation Market – The global Microencapsulation market is estimated to be valued at USD 6.5 billion in 2022 and is projected to reach USD 10.3 billion by 2032, at a CAGR of 8.2% from 2022 to 2032.

Food Amino Acids Market – The food amino acids market was estimated at USD 4.9 billion in 2017 and is projected to grow at a CAGR of 8.1 % from 2018, to reach a value of USD 6.6 billion by 2022. The global food amino acids market is estimated to be USD 11.6 billion in 2032

Contact Us:                                                      

Future Market Insights
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: [email protected]
For Media Enquiries: [email protected]
Website: https://www.futuremarketinsights.com